BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/11/2025 8:20:56 AM | Browse: 6 | Download: 3
 |
Received |
|
2025-07-01 09:08 |
|
Peer-Review Started |
|
2025-07-01 09:08 |
|
First Decision by Editorial Office Director |
|
2025-07-24 08:02 |
|
Return for Revision |
|
2025-07-24 08:02 |
|
Revised |
|
2025-08-07 03:33 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-14 02:46 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-15 05:48 |
|
Articles in Press |
|
2025-10-15 05:48 |
|
Edit the Manuscript by Language Editor |
|
2025-10-29 10:51 |
|
Typeset the Manuscript |
|
2025-12-01 11:13 |
|
Publish the Manuscript Online |
|
2025-12-11 08:20 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pharmacology & Pharmacy |
| Manuscript Type |
Retrospective Study |
| Article Title |
Investigating radiotherapy’s impact on intestinal perforation risk in gastrointestinal tumor patients treated with bevacizumab
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei-Mei He and Wen-Si Li |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wen-Si Li, Chief Pharmacist, Department of Infirmary, Guilin Tourism University, No. 26 Liangfeng Road, Yanshan District, Guilin 541006, Guangxi Zhuang Autonomous Region, China. leelee71@163.com |
| Key Words |
Radiotherapy; Bevacizumab; Colon cancer; Intestinal perforation; Combination therapy |
| Core Tip |
This study investigates the risk of intestinal perforation in gastrointestinal tumor patients treated with radiotherapy combined with bevacizumab vs bevacizumab alone. While radiotherapy and bevacizumab are essential for managing advanced gastrointestinal cancers, both treatments can cause gastrointestinal complications, including perforation. The study compares the incidence of intestinal perforation and survival outcomes, aiming to inform clinical decision-making and enhance patient safety. |
| Publish Date |
2025-12-11 08:20 |
| Citation |
He WM, Li WS. Investigating radiotherapy’s impact on intestinal perforation risk in gastrointestinal tumor patients treated with bevacizumab. World J Gastrointest Oncol 2025; 17(12): 110621 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i12/110621.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i12.110621 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
